Responses
Speaker abstracts 2001
Osteoarthritis – Clinical aspects and treatment
OP0048 A double-blind, placebo-controlled dose ranging study to evaluate the efficacy of valdecoxib, a novel cox-2 specific inhibitor, in treating the signs and symptoms of osteoarthritis of the knee
Compose a Response to This Article
Other responses
No responses have been published for this article.